Partnership for the MJFF Parkinson's Therapeutic Pipeline Program

Find a Collaborator
1

:brain: Partner with a Neurobiologist & Consultant for the MJFF Parkinson’s Therapeutics Pipeline Program

The Michael J. Fox Foundation (MJFF) Parkinson’s Disease Therapeutics Pipeline Program offers massive funding ($250K to $5M+), but the criteria are incredibly strict. MJFF explicitly excludes early-stage target discovery, simple reformulations, and standalone platforms.

They want milestone-driven, disease-modifying, or symptomatic interventions with a clear, viable path to commercialization.

If your institution or industry team is preparing a pre-proposal or has been invited to submit a full proposal, the difference between a rejection and a multi-million dollar award often comes down to how sharply your translational science and biomarker strategies are defined.

That is where I come in.

As a consultant and neurobiologist, I serve as the strategic “brainbox” for institutions and biotech teams navigating complex CNS drug discovery pipelines.

How We Can Collaborate:

  1. Translational Strategy & Milestone Mapping:

Aligning your pre-clinical or clinical programs directly with MJFF’s strict commercial viability requirements.

  1. Biomarker Integration:

Designing decision-informing biomarker tools that meet the foundation’s core funding pillars.

  1. Proposal De-risking:

Reviewing your therapeutic rationale to ensure it cleanly avoids MJFF’s explicit exclusion traps (such as tool-compound validation gaps or lack of regulatory clarity).

  1. Open Science Compliance:

Structuring your project outputs to seamlessly align with MJFF’s mandatory Open Science Policy.

Whether you are an academic-led project looking for industry-grade positioning or a biotech team needing deep neurobiology expertise to solidify your proposal, let’s collaborate to build a compelling, bulletproof application.

:envelope_with_arrow: Let’s connect. DM me or reach out directly to discuss how we can maximize your project’s funding potential for the upcoming 2026 review cycles.

#ParkinsonsDisease #Neurobiology #CNSDrugDiscovery #BiotechConsulting #MJFF #MedicalResearch #NeurodegenerativeDisease #ResearchFunding

2

Hi Benjamin,

While I don’t necessarily fit the description of individuals you are looking for, I just wanted to say that I am happy to see these types of post looking for collaboration for grant applications in the community, and wish you success in finding collaborators!